INT-767 also reduced hypercholesterolemia by FXR activation and induced thermogenic gene expression through TGR5 and/or FXR activation, which led to the reversal of the HFD-induced metabolic disorders [134]. Here, NR1H4 is linked to Hypercholesterolemia.